Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.

Kidney international - 1 Aug 2016

Ma Lijun, Langefeld Carl D, Comeau Mary E, Bonomo Jason A, Rocco Michael V, Burkart John M, Divers Jasmin, Palmer Nicholette D, Hicks Pamela J, Bowden Donald W, Lea Janice P, Krisher Jenna O, Clay Margo J, Freedman Barry I

Abstract excerpt

Relative to European Americans, evidence supports that African Americans with end-stage renal disease (ESRD) survive longer on dialysis. Renal-risk variants in the apolipoprotein L1 gene (APOL1), associated with nondiabetic nephropathy and less subclinical atherosclerosis, may contribute to dialysis outcomes. Here, APOL1 renal-risk variants were assessed for association with dialytic survival in 450 diabetic and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein L1
Share to Apolipoproteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Black or African American

Share to Diabetic Nephropathies

Share to Kidney Failure, Chronic

Share to Kidney Transplantation

Share to Lipoproteins, HDL

Share to Renal Dialysis

Source

Open in PubMed Open full text

Identifiers

PMID: 27157696
DOI: 10.1016/j.kint.2016.02.032
PMCID: PMC4946964

Genes

APOL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.PMID 27157696Read ↗

APOL1 risk variants and death among African American hemodialysis patients: survival of the fittest?Semantic proximity Read ↗

APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.Semantic proximity Read ↗

APOL1-Associated Kidney Disease in BrazilSemantic proximity Read ↗

The evolving science of apolipoprotein-L1 and kidney disease.Semantic proximity Read ↗

Genetic variation in APOL1 associates with younger age at hemodialysis initiation.Semantic proximity Read ↗

APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension).Semantic proximity Read ↗

Population-based risk assessment of APOL1 on renal disease.Semantic proximity Read ↗

The Apolipoprotein L1 Gene and Cardiovascular Disease.Semantic proximity Read ↗

APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.Semantic proximity Read ↗

Apolipoprotein L1 (APOL1) and Nephropathy.Semantic proximity Read ↗

Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways.Semantic proximity Read ↗

Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.